Induction of morphological differentiation in the human leukemic cell line K562 by exposure to thalidomide metabolites
- 31 December 1991
- journal article
- Published by Elsevier in Leukemia Research
- Vol. 15 (2-3) , 129-136
- https://doi.org/10.1016/0145-2126(91)90093-9
Abstract
No abstract availableKeywords
This publication has 6 references indexed in Scilit:
- Clinical pharmacology of sodium butyrate in patients with acute leukemiaEuropean Journal of Cancer and Clinical Oncology, 1987
- Expression of myeloid-specific antigens on two human erythroleukaemia cell lines, HEL and K562Leukemia Research, 1984
- Megakaryoblastic differentiation of proerythroblastic K562 cell-line cellsLeukemia Research, 1984
- Properties and usefulness of the original K-562 human myelogenous leukemia cell lineLeukemia Research, 1979
- Induction of erythroid differentiation in the human leukaemia cell line K562Nature, 1979
- Human chronic myelogenous leukemia cell-line with positive Philadelphia chromosomeBlood, 1975